by admin | Jan 19, 2026 | News & Opinions
by University of New South Wales – Science Daily – A new CRISPR breakthrough shows scientists can turn genes back on without cutting DNA, by removing chemical tags that act like molecular anchors. The work confirms these tags actively silence genes,...
by admin | Jan 16, 2026 | News & Opinions
by Charles Bankhead – MedPageToday – Long-term survival in the CARTITUDE-1 trial showed that almost half of patients remained, alive with a median overall survival (OS) of 60.7 months. Almost three-fourths of the survivors remained progression free, and...
by admin | Jan 15, 2026 | News & Opinions
By Julie Grisham – Memorial Sloan Kettering Cancer Center – When it comes to giving immunotherapy to people with the most common form of lymphoma, the time of day may make a difference, according to new research from Memorial Sloan Kettering Cancer Center...
by admin | Jan 14, 2026 | News & Opinions
By Chinese Academy of Sciences – SciTechDaily – A new method for engineering natural killer cells could make cancer immunotherapy more efficient, scalable, and affordable, potentially reshaping how these treatments are produced. Chinese scientists have...
by admin | Jan 13, 2026 | News & Opinions
By Frank Vinluan – MedCity News – A rare but severe stem cell transplant complication that often becomes fatal now has its first FDA-approved treatment, a therapy developed by biotechnology company Omeros. Omeros’s complement system drug Yartemlea is now...
